Bristol-Myers falls on kidney cancer drug trial results

CNBC's Meg Tirrell reports on Bristol-Myers falling after its kidney cancer drug trial results. Also, more on Merck's CEO's decision to leave the President's manufacturing council.
01:44
Tue, Aug 15 20174:56 PM EST